Published: 2017-12-22

A prospective study of surgical site infection of orthopedic implant surgeries

Muhammad Thahir, Suresh Gandhi, Kalaivanan Kanniyan, Ravi Kumar


Background: Surgical-site infection accounts for approximately 10% of all hospital-acquired infections, which are estimated to double the cost of care and result in an additional mean of 6.5 days of hospital stay. We did prospective study of surgical site infection of orthopaedic implant surgeries.

Methods: The aim of the study is to assess the clinical and microbiological outcome of 125 patients who had open reduction and internal fixation with implants and prosthesis at Southern Railway Hospital from January 2006 to January 2007, and its strength of association with major risk factors using univariate analysis. In our study, Patients were allocated in to three groups as NINS risk index group 0, 1 and 2 with risk factors as duration of surgery >2 hours and ASA class ≥3. Post-operative wound infection was diagnosed based on the criteria of Center of Disease Control and assessed for the period of 6 weeks using National Nosocomial Infections Surveillance Risk Index.

Results: There were 87 male and 38 females in the study. From 125 Patients, 13 patients had post-operative superficial surgical site infection and presented within 21 days of operation. The infection rate was 10.4%. Two Patients developed deep infection after 6 weeks of study. All the cases with superficial infection were followed at regular intervals, 11 cases resolved with regular dressing and antibiotics but 2 cases continued to discharge sinus up to 3 months.

Conclusions: The study showed that the risk of infection rate increased significantly with ASA score, duration of surgery, obesity and NINS risk index. There was no significant association of infection rate with age, diabetes and smoking. 


Surgical Site Infection, NINS risk index, ASA class

Full Text:



Schatzker J. Principles of stable internal fixation. In: Schatzker J, Tile M (eds) The rationale of operative fracture Care. Spinger-Verlag, Berlin; 1996: 10-11.

Sisk DT. General principles of fracture treatment. In: Crenshaw AH (ed) Campbell’s operative orthopaedics. Mosby, Missouri; 1987: 1551–1561.

Whyte W, Hodgson R, Tinkler J. The importance of airborne bacterial contamination of wounds. J Hosp Infect. 1982;3:123-35.

Haley RW, Culver DH, White JW, Morgan WM, Emori TG, Munn VP, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infection in the US hospitals. Am J Epidemiol. 1985;121:182-205.

Neut D. Biomaterial-associated infections in orthopaedics-prevention and detection-. Thesis, University of Groningen, 2003.

Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318-22.

Gurkan I, Wenz JF Sr. Perioperative Infection Control: An Update for Patient Safety in Orthopedic Surgery. Orthopedics. 2006;29:329.

Selwyn S, Ellis H. Skin bacteria and skin disinfection reconsidered. Br Med J. 1972;1:136-40.

Kaul AF, Jewett JF. Agents and techniques for disinfection of the skin. Surg Gynecol Obstet. 1981;152:677-85.

Bethune DW, Blowers R, Parker M, Pask EA. Dispersal of Staphylococcus aureus by patients and surgical staff. Lancet. 1965;1:480-3.

Knobben BA, van Horn HC, Bussher HJ. Evaluation of measures to decrease intraoperative bacterial contamination in orthopaedic implant Surgery. J Hosp Infect. 2006;62:174-80.

Owers KL, James E, Bannister GC, Source of bacterial shedding in Laminar flow theatre. J Hosp Infect. 2004;58:230-2.

Pryor F, Messmer PR. The effect of traffic patterns in the OR on surgical site infections. AORN J. 1998;68:649-60.

Boyd RJ, Burke JF, Colton T. A double blind clinical trial of prophylactic antibiotics in hip fractures. J Bone Joint Surg Am. 1973;55:1251-8.

Hill C, Flamant R, Mazas F, Evrard J. Prophylactic cefazolin versus placebo in total hip replacement, Report of multicentric double blind randomized trial. Lancet. 1981;1:795-6.

Boxma H, Broekhuizen T, Patka P. Randomised control trial of single-dose antibiotic prophylaxis in closed fractures. Dutch trauma Lancet. 1996;347:1133-7.

Gillespie WJ, Walenkamp G, Antibiotic prophylaxis for surgery for femoral and other closed long bone fractures. Cochrane Database Syst Rev. 2000;2:CD000244.

Page CP, Bohnen JM, Fletcher JR. Antimicrobial prophylaxis for surgical wounds, Guidelines for clinical care. Arch Surg. 1993;128:79-88.

Gilbert DN, Moellering RC. The Stanford guide to antimicrobial therapy, 35th ed. Hyde park, VT. Antimicrobial Therapy. 2005: 125.

Hanssen AD, Osmon DR. The use of prophylactic antimicrobial agents during and after Hip arthroplasty. Clin Orthop Relat Res. 1999;369:123-38.

American academy of orthopaedic surgeon. Advisory statement, Recommendations for the use of intravenous antibiotic prophylaxis in primaru total hip repalcement. Available at: Accessed on 3 August 2017.

Nelson Cl, Green TG. One day versus seven days of preventive antibiotics therapy in orthopaedic surgery, Clin Orthop Relat Res. 1983;176:258-63.

Heydemann JS, Nelson CL. Short term preventive antibiotics, Clin Orthop Relat Res. 1986;205:184-7.

Adedeji O. Microbiology of post-operative wound infection in implant surgery. Nigerian J Surg Res. 2004;6(1):37–40.

Marculescu CE, Berbari EF, Hanssen AD, Steckelberg JM, Harmsen SW, Mandrekar JN, et al. Outcome of prosthetic joint infections treated with debridement and retention of components; Clin Infect Dis. 2006;42(4):471-8.

Olsen MA, Nepple JJ, Riew D, Lenke LG, Bridwell KH, Mayfield J, et al. Fraser, Risk Factors for Surgical Site Infection following Orthopaedic Spinal Operations. J Bone Joint Surg Am. 2008;90:62-9.